Sangamo Therapeutics
SGMO
#8725
Rank
S$0.21 B
Marketcap
S$0.64
Share price
-6.45%
Change (1 day)
-75.63%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of September 2025 : S$8.09 Million

According to Sangamo Therapeutics 's latest financial reports the company has S$8.09 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$30.95 M-71.73%
2023-12-31$S$0.10 B-72.32%
2022-12-31$S$0.39 B-22.07%
2021-12-31$S$0.50 B-22.88%
2020-12-31$S$0.65 B12.78%
2019-12-31$S$0.58 B16.28%
2018-12-31$S$0.50 B99.64%
2017-12-31$S$0.25 B27.5%
2016-12-31$S$0.19 B-27.59%
2015-12-31$S$0.27 B-0.3%
2014-12-31$S$0.27 B77.06%
2013-12-31$S$0.15 B94.31%
2012-12-31$S$79.36 M-23.53%
2011-12-31$S$0.10 B44.1%
2010-12-31$S$72.01 M-28.54%
2009-12-31$S$0.10 B27.21%
2008-12-31$S$79.22 M-23.67%
2007-12-31$S$0.10 B38.96%
2006-12-31$S$74.68 M18.62%
2005-12-31$S$62.96 M19.2%
2004-12-31$S$52.81 M-30.39%
2003-12-31$S$75.87 M-19.38%
2002-12-31$S$94.12 M-38.26%
2001-12-31$S$0.15 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
S$27.80 B 343,580.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.30 B 3,646.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$12.46 B 153,976.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$23.59 B 291,546.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$24.70 B 305,266.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$102.73 B 1,269,754.24%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$7.84 B 96,916.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$67.26 B 831,343.22%๐Ÿ‡บ๐Ÿ‡ธ USA